ID: ALA410242

Max Phase: Preclinical

Molecular Formula: C26H31NO3

Molecular Weight: 405.54

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): 16Beta-(M-Carbamoylbenzyl)Estradiol
Synonyms from Alternative Forms(1):

    Canonical SMILES:  C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@H](Cc1cccc(C(N)=O)c1)[C@@H]2O

    Standard InChI:  InChI=1S/C26H31NO3/c1-26-10-9-21-20-8-6-19(28)13-16(20)5-7-22(21)23(26)14-18(24(26)29)12-15-3-2-4-17(11-15)25(27)30/h2-4,6,8,11,13,18,21-24,28-29H,5,7,9-10,12,14H2,1H3,(H2,27,30)/t18-,21+,22+,23-,24-,26-/m0/s1

    Standard InChI Key:  RSVOVHDOLNWYER-RYZVYYIHSA-N

    Associated Targets(Human)

    Estradiol 17-beta-dehydrogenase 1 2224 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Estradiol 17-beta-dehydrogenase 2 1671 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    T47D 39041 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    MCF7 126967 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Cytochrome P450 3A4 53859 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Estradiol 17-beta-dehydrogenase 12 18 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    3-keto-steroid reductase 330 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 405.54Molecular Weight (Monoisotopic): 405.2304AlogP: 4.18#Rotatable Bonds: 3
    Polar Surface Area: 83.55Molecular Species: NEUTRALHBA: 3HBD: 3
    #RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 10.33CX Basic pKa: CX LogP: 4.54CX LogD: 4.54
    Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.72Np Likeness Score: 1.46

    References

    1. Laplante Y, Cadot C, Fournier MA, Poirier D..  (2008)  Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.,  16  (4): [PMID:18035543] [10.1016/j.bmc.2007.11.007]
    2. Ouellet E, Ayan D, Poirier D..  (2011)  Synthesis and preliminary evaluation of a modified estradiol-core bearing a fused γ-lactone as non-estrogenic inhibitor of 17β-hydroxysteroid dehydrogenase type 1.,  21  (18): [PMID:21782424] [10.1016/j.bmcl.2011.06.110]
    3. Maltais R, Ayan D, Poirier D..  (2011)  Crucial Role of 3-Bromoethyl in Removing the Estrogenic Activity of 17β-HSD1 Inhibitor 16β-(m-Carbamoylbenzyl)estradiol.,  (9): [PMID:21927646] [10.1021/ml200093v]
    4. Maltais R, Ayan D, Trottier A, Barbeau X, Lagüe P, Bouchard JE, Poirier D..  (2014)  Discovery of a non-estrogenic irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 from 3-substituted-16β-(m-carbamoylbenzyl)-estradiol derivatives.,  57  (1): [PMID:24328103] [10.1021/jm401639v]

    Source